| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/29/2001 | WO2001021136A2 Compositions and methods for improved detection and classification of neoplasms |
| 03/29/2001 | WO2001020989A1 Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
| 03/29/2001 | WO2001002557A8 Neurotrophic factor receptor |
| 03/29/2001 | WO2000077026A8 49 human secreted proteins |
| 03/29/2001 | WO2000073430A3 Vaccines against conformation-dependent antigens and against antigens that are not or are not only proteins or peptides |
| 03/29/2001 | WO2000061067A3 Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein |
| 03/29/2001 | WO2000058005A3 Immunoadsorber for use in sepsis therapy |
| 03/29/2001 | WO2000034436A9 Facs assisted methods for introducing individual chromosomes into cells |
| 03/29/2001 | WO2000032775A9 Pth1r and pth3r receptors |
| 03/29/2001 | WO2000032635A9 Tumor specific human monoclonal antibodies and methods of use |
| 03/29/2001 | WO1999013083A9 Method and means for modulating plant cell cycle proteins and their use in controlling plant cell growth |
| 03/29/2001 | US20010000075 Neurotactin and uses therefor |
| 03/29/2001 | CA2387695A1 A novel member of the heparanase protein family |
| 03/29/2001 | CA2385879A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385783A1 A pcam-1 marker protein, nucleic acid sequences encoding pcam-1 and immunoassays for detection of pcam-1 |
| 03/29/2001 | CA2385664A1 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| 03/29/2001 | CA2385552A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | CA2385480A1 32 human secreted proteins |
| 03/29/2001 | CA2385460A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
| 03/29/2001 | CA2385428A1 Novel pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385425A1 Pcna associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385334A1 Novel syk kinase-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2385235A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2384812A1 Method and compositions for inhibiting adhesion formation |
| 03/29/2001 | CA2383838A1 Method of fractional measurement of soluble cd14 protein |
| 03/29/2001 | CA2383615A1 Methods for diagnosis and therapy of hematological and virus-associated malignancies |
| 03/29/2001 | CA2383591A1 Cell based assay |
| 03/29/2001 | CA2383462A1 Therapeutic methods and compounds |
| 03/29/2001 | CA2383276A1 Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
| 03/29/2001 | CA2350700A1 Coupling factor 6 inhibitor and potentiator and use thereof |
| 03/29/2001 | CA2319213A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 03/28/2001 | EP1087013A2 Immunoglobulins devoid of light chains |
| 03/28/2001 | EP1087012A1 Groups of genes expressed in human dendritic cells |
| 03/28/2001 | EP1086956A1 Gene recombinant antibodies |
| 03/28/2001 | EP1086705A1 Vegf activity inhibitors |
| 03/28/2001 | EP1086234A1 New human carboxypeptidase inhibitor |
| 03/28/2001 | EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 03/28/2001 | EP1086223A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/28/2001 | EP1086222A2 Cell cycle regulation proteins |
| 03/28/2001 | EP1086219A2 Proteins regulating gene expression |
| 03/28/2001 | EP1086218A2 Genes and gene expression products that are differentially regulated in prostate cancer |
| 03/28/2001 | EP1086213A2 Human genes differentially expressed in colon cancer |
| 03/28/2001 | EP1086138A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 03/28/2001 | EP1086137A1 Composition and method for modulating dendritic cell-t cell interaction |
| 03/28/2001 | EP1086136A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples |
| 03/28/2001 | EP1086135A2 "monoclonal anitbody and assay for detecting n-terminal procollagen (iii) propeptide (piiinp)" |
| 03/28/2001 | EP1086134A2 Methods to prepare antibodies which bind to posttranslationally modified amino acids within peptides |
| 03/28/2001 | EP1086129A1 Anti-angiogenic proteins and methods of use thereof |
| 03/28/2001 | EP1086125A1 Respiratory nitrate reductase alpha subunit |
| 03/28/2001 | EP1086119A1 Purification of antibodies |
| 03/28/2001 | EP1085908A2 Recombinant immunotoxin directed against the hiv-1 gp120 envelope glycoprotein |
| 03/28/2001 | EP1085906A1 Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease |
| 03/28/2001 | EP1085905A1 Immunotherapeutic composition and method for the treatment of prostate cancer |
| 03/28/2001 | EP1085903A1 Egg surface proteins and methods for use for modulating fertility |
| 03/28/2001 | EP1085902A2 Therapeutic compositions that produce an immune response by altering the antigen |
| 03/28/2001 | EP1085897A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085882A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP0221173B1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof |
| 03/28/2001 | CN1289373A Inhibition of DNA modulation caused by mutated p53 |
| 03/28/2001 | CN1289253A Treating atopic dermatitis with lgE antagonists |
| 03/28/2001 | CN1289252A Treatment of follicular lymphomas using inhibitors of the lymphotoxin (LT) pathway |
| 03/28/2001 | CN1288950A Preparation and application of monocloning antibody based on DNA immunity |
| 03/28/2001 | CN1063792C Hamanized antibodies and uses thereof |
| 03/28/2001 | CN1063758C Sulphur-35 labeled single clone antibody and its preparing method |
| 03/27/2001 | US6207880 Plants which synthesize a modified starch, process for the production thereof and modified starch |
| 03/27/2001 | US6207815 Dna coding for chimeric heavy chain or antigen binding fragment produced by specific cell lines; combines with high molecular weight, tumor-associated sialylated glycoprotein antigen light chain; diagnosis; imaging |
| 03/27/2001 | US6207814 Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them |
| 03/27/2001 | US6207811 Nephrin gene and protein |
| 03/27/2001 | US6207807 Immobilizing a peptide which binds to fc region of antibody onto an affinity chromatography support, packing into column, equilibrating with buffer, applying solution to column, washing with eluent to remove impurites, eluting antibodies |
| 03/27/2001 | US6207805 Hybridoma which secretes monoclonal antibodies; diagnosis; anticarcinogenic agents with reduced side effects; imaging |
| 03/27/2001 | US6207804 Genetically engineered antibody analogues and fusion proteins thereof |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207802 Non-human, mammalian polypeptide of defined amino acid sequence which activates the growth of early hematopoietic progenitor cells; treatment of blood disorders; anticarcinogenic agents; bone marrow regeneration |
| 03/27/2001 | US6207801 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
| 03/27/2001 | US6207799 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 03/27/2001 | US6207647 Polynucleotides and polypeptides of the rat family, referred to as ?rata?; treatment of chlamydia infections |
| 03/27/2001 | US6207645 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations |
| 03/27/2001 | US6207642 Member of the TNF family useful for treatment and diagnosis of disease |
| 03/27/2001 | US6207641 Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases |
| 03/27/2001 | US6207454 Exposing target mammalian cell that expresses stem cell factor receptor to active stem cell factor or analog, then introducing polynucleotide to cell; gene therapy |
| 03/27/2001 | US6207452 Antibody of the anti-proliferation domain of human Bcl-2 |
| 03/27/2001 | US6207449 Nucleotide sequence of gene; hybridization probes for detection; drug screening for bactericides, bacteriostats and antibiotics |
| 03/27/2001 | US6207432 Tyrosylprotein sulfotransferases and methods of use thereof |
| 03/27/2001 | US6207418 Production of a multimeric protein by cell fusion method |
| 03/27/2001 | US6207417 DNA encoding stem cell factor |
| 03/27/2001 | US6207414 Combining protein or peptide or polypetide with tyrosylprotein sulfotransferase and 3'-phosphoadenosine 5'-phosphosulfate to cause transfer of sulfate from phosphosulfate to tyrosine of the protein or peptide |
| 03/27/2001 | US6207413 Nucleotide sequence coding binding protein; for the diagnosis and treatment of endocrine defects |
| 03/27/2001 | US6207401 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 03/27/2001 | US6207398 Lysing red blood cells in a sample of whole blood containing cyclosporin a, contacting the sample with excess of labeled anti-cyclosporin antibody to form a complex, separating unbound antibody, contacting complex with cyclosporins |
| 03/27/2001 | US6207395 Diagnostic assays for detection of Entamoeba histolytica |
| 03/27/2001 | US6207386 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
| 03/27/2001 | US6207383 Adjusted nucleotide sequences associated with genetic disorder; for the diagnosis, treatment and prevention of arrhythmia |
| 03/27/2001 | US6207380 Detecting urogenital disorders; provide sample and incubate with diagnostic probes, detect amplified expression of target polynucleotides, an amplified presence of target nucleotide sequences indicates urogenital disorder |
| 03/27/2001 | US6207374 Tuberous sclerosis 2 gene and uses thereof |